Zhejiang Medicine Co., Ltd. (SHA:600216)
11.14
-0.14 (-1.24%)
Nov 6, 2026, 3:00 PM CST
Zhejiang Medicine Market Cap
Zhejiang Medicine has a market cap or net worth of 10.56 billion as of November 6, 2026. It is the 7,563rd most valuable company in the world and the 1,492nd biggest in China. Its market cap has decreased by 23.07% in one year.
Market Cap
10.56B
Enterprise Value
8.11B
Revenue
8.43B
Global Rank
Country Rank
#1,492 China
PE Ratio
16.92
ChartMarket Cap Chart
Since January 2, 2001, Zhejiang Medicine's market cap has increased from 5.53B to 10.56B, an increase of 90.86%. That is a compound annual growth rate of 2.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 10.56B | -19.62% |
| Dec 31, 2025 | 13.14B | -13.86% |
| Dec 31, 2024 | 15.25B | 48.35% |
| Dec 29, 2023 | 10.28B | -8.23% |
| Dec 30, 2022 | 11.20B | -31.56% |
| Dec 31, 2021 | 16.37B | 25.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Aosaikang Pharmaceutical | 11.87B |
| Shanghai Shyndec Pharmaceutical | 11.21B |
| PharmaBlock Sciences (Nanjing) | 11.17B |
| Zhejiang CONBA Pharmaceutical | 11.05B |
| Yantai Dongcheng Pharmaceutical Group | 10.93B |
| Mayinglong Pharmaceutical Group | 10.76B |
| Guilin Sanjin Pharmaceutical | 10.32B |
| Guangdong Taienkang Pharmaceutical | 10.23B |